ASX/NEU (ASX/NEU)

Australian Securities Exchange: ASX/NEU · AUD

A$19.0

+0.25 (+1.3%)· Recorded snapshot

Market cap	2.4B
Revenue (ttm)	69.5M
Net income (ttm)	20.3M
EPS (ttm)	A$0.16
Shares out	126.8M
P/E (trailing)	121.5x
P/E (forward)	37.8x
Dividend	A$0.30 (1.58%)
Volume	357,585
Beta	1.57

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 69.5M
Net income (ttm): 20.3M
EPS (ttm): A$0.16
P/E (trailing): 121.5x
P/E (forward): 37.8x
Market cap: 2.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E37.8

P25 n/aP50 n/aP75 n/a

Trailing P/E121.5

P25 n/aP50 n/aP75 n/a

ROE6.2

P25 n/aP50 n/aP75 n/a

ROIC22.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ASX/NEU indicators

Market & fundamental data

Available fields

244

Groups with data

Currency

AUD

Showing 244 of 244 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	New Zealand
Country code	AU
Earnings date	2026-11-26
Employees	8
Enterprise value	AUD 2.1B
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2001
In index	ASX200
Industry	Biotechnology
Is primary listing	Yes
ISIN number	NZNEUE0001S8
Last earnings date	2026-08-26
Last refreshed	2026-10-28
Last stock split date	2017-11-21
Last stock split type	Reverse
Market cap	AUD 2.4B
Next earnings date	2026-11-26
Price	AUD 18.95
Price currency	AUD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	asx/NEU
Website	https://www.neurenpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	120.16x
Average P/E ratio (3Y)	33.32x
Average P/E ratio (5Y)	395.5x
Earnings yield	0.82%
EV/Earnings	104.45x
EV/EBIT	152.63x
EV/EBITDA	152.35x
EV/FCF	416.75x
EV/Sales	30.43x
FCF / EV yield	0.24%
FCF yield	0.21%
Forward P/E	37.82x
Graham number	3.03734
Graham upside	-83.97%
Industry forward P/E	28.34x
Lynch fair value	AUD 0.78
Lynch upside	-95.89%
P/(FCF - SBC) ratio	8,519.03x
P/(OCF - SBC) ratio	7,460.77x
P/B ratio	7.21x
P/E ratio	121.54x
P/FCF ratio	473.19x
P/OCF ratio	469.49x
P/S ratio	34.55x
Price / tangible book value	7.21x
Price/EBITDA ratio	172.98x
Sector forward P/E	34.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	19.94%
EBITDA margin	19.97%
Effective tax rate	24.45%
FCF margin	7.3%
Gross margin	29.64%
Operating margin	19.94%
Pretax margin	38.57%
Profit margin	29.14%
Profit per employee	AUD 2.5M
Profitable quarters	8
Profitable years	4
Revenue per employee	AUD 8.7M
ROA	2.58%
ROA (5Y)	21.26%
ROCE	4.16%
ROE	6.17%
ROE (5Y)	32.35%
ROIC	22.36%
SBC / revenue	6.9%
Tax / revenue	9.43%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-86.42%
EPS growth (Q)	-67.3%
EPS growth (QoQ)	-67.21%
EPS growth 3Y	-28.13%
EPS growth years	0
FCF growth	-96.31%
FCF growth (Q)	-93.77%
FCF growth 3Y	-54.6%
Gross profit growth	-89.09%
Gross profit growth (Q)	-57.16%
Gross profit growth 3Y	-29.37%
Net income growth	-86.41%
Net income growth (Q)	-67.72%
Net income growth (QoQ)	-68.5%
Net income growth 3Y	-28.34%
Net income growth years	0
OCF growth	-96.28%
OCF growth (Q)	-93.76%
OCF growth 3Y	-54.49%
Operating income growth	-92.47%
Operating income growth (Q)	-75.04%
Operating income growth 3Y	-36.74%
Revenue growth	-68.23%
Revenue growth (Q)	17.25%
Revenue growth (QoQ)	-8.84%
Revenue growth 10Y	77.58%
Revenue growth 3Y	-3.9%
Revenue growth 5Y	149.65%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -40,000
Depreciation and amortization	AUD 26,000
EBIT	AUD 13.9M
EBITDA	AUD 13.9M
EPS	AUD 0.16
FCF per share	AUD 0.04
Financing cash flow	AUD 2.8M
Free cash flow	AUD 5.1M
Free cash flow minus SBC	AUD 282,000
Gross profit	AUD 20.6M
Income taxes	AUD 6.6M
Investing cash flow	AUD 16.4M
Net cash flow	AUD 21M
Net income	AUD 20.3M
Operating cash flow minus SBC	AUD 322,000
Operating income	AUD 13.9M
Revenue	AUD 69.5M
Stock-based compensation	AUD 4.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	172.71
Book value per share	AUD 2.63
Debt / equity	0
Long-term assets	AUD 7.1M
Long-term liabilities	AUD 62,000
Net cash (debt)	AUD 286.5M
Net cash / market cap	11.93%
Net cash growth	-4.34%
Net debt / EBITDA	-20.63
Net debt / equity	-0.86
Net debt / FCF	-56.44
Piotroski F-Score	4
Property, plant and equipment	AUD 38,000
Shareholders' equity	AUD 333.4M
Tangible book value	AUD 333.4M
Tangible book value per share	AUD 2.63
Total assets	AUD 340.6M
Total cash	AUD 286.5M
Total debt	AUD 0
Total liabilities	AUD 7.2M
WACC	12.87%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.21
Current assets	AUD 333.5M
Current liabilities	AUD 7.2M
Current ratio	46.45
Net working capital	AUD 39.8M
Quick ratio	44.56
Working capital	AUD 326.3M
Working capital turnover	0.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-10-07
Dividend payment years	1
Dividend per share	AUD 0.30
Dividend yield	1.58%
Ex-dividend date	2026-09-15
FCF payout ratio	374.55%
Last dividend	AUD 0.15
Payout ratio	96.2%
Shareholder yield	1.58%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	2,005.56%
10Y return CAGR	35.73%
10Y total return	2,020.95%
150-day SMA	AUD 16.83
15Y price change	3,167.24%
15Y return CAGR	26.23%
15Y total return	3,191.13%
1D price change	1.34%
1M price change	-6.28%
1M total return	-6.28%
1W price change	-3.81%
1W total return	-3.81%
1Y price change	-11.12%
1Y return CAGR	-10.47%
1Y total return	-10.47%
20-day SMA	AUD 19.75
200-day SMA	AUD 16.07
20Y price change	112.92%
20Y return CAGR	4.8%
20Y total return	155.6%
3M price change	13.47%
3M total return	14.3%
3Y price change	85.24%
3Y return CAGR	23.11%
3Y total return	86.59%
50-day SMA	AUD 20.32
50-day SMA vs 200-day SMA	50over200
52-week high	AUD 23.76
52-week high date	2026-08-12
52-week low	AUD 11.00
52-week low date	2026-03-23
5Y price change	924.32%
5Y return CAGR	59.5%
5Y total return	931.81%
6M price change	55.33%
6M total return	56.46%
All-time high	AUD 25.95
All-time high date	2023-12-28
All-time low	AUD 0.06
All-time low date	2009-03-05
Average true range (ATR)	AUD 0.73
Average volume	317.2K
Beta (1Y)	1.82
Beta (2Y)	1.78
Beta (5Y)	1.57
Change from 52-week high	-20.24%
Change from 52-week low	72.27%
Change from all-time high	-26.97%
Change from all-time low	31,483.33%
Change from open	-0.16%
Day's gap	1.5%
Dollar volume	AUD 6.8M
High price	AUD 19.63
Low price	AUD 18.51
Monthly RSI	56.4
Open price	AUD 18.98
Position in 52-week range	39.29%
Previous close	AUD 18.70
Price vs 150-day SMA	12.57%
Price vs 20-day SMA	-4.05%
Price vs 200-day SMA	17.94%
Price vs 50-day SMA	-6.76%
Relative volume	1.15
RSI	39.07
Sharpe ratio	0.02
Sharpe ratio (3Y)	0.57
Sharpe ratio (5Y)	0.91
Sortino ratio	0.15
Sortino ratio (3Y)	1.08
Sortino ratio (5Y)	2.06
Volume	357.6K
Weekly RSI	53.01
YTD price change	1.83%
YTD total return	2.57%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	109.9M
Shares change (QoQ)	-4.05%
Shares change (YoY)	0%
Shares held by insiders	2.98%
Shares held by institutions	22.71%
Shares outstanding	126.8M

Deeper analysis on ASX/NEU

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/NEU report

Is a complete ASX/NEU research report available?

No complete published report is available for asx/NEU (ASX/NEU) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/NEU (ASX/NEU)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/NEU

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/NEU indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/NEU

Frequently asked questions